Form 4: Cigna EVP Koka Prasad Reports Equity Transactions

Sentiment:

Insider Transaction Report


Cigna's EVP, Global CIO, Durga Prasad Koka, disclosed the acquisition of common stock and stock options, alongside tax-related share dispositions, stemming from performance and restricted share settlements.

Summary

  • EVP, Global CIO Durga Prasad Koka acquired 499 shares of Cigna common stock on February 27, 2026, resulting from the settlement of strategic performance shares for the 2023-2025 period, based on company performance goals.
  • Acquired an additional 2,678 restricted shares of common stock on February 27, 2026, which will vest in three equal annual installments starting March 1, 2027.
  • Disposed of 122 shares of common stock at $287.55 per share on February 27, 2026, to cover tax obligations related to the settlement of strategic performance shares.
  • Disposed of 98 shares of common stock at $287.55 per share on February 27, 2026, to cover tax obligations upon the vesting of restricted shares.
  • Acquired 4,127 employee stock options with an exercise price of $287.5475 on February 27, 2026, which will vest in three equal annual installments beginning March 1, 2027, and expire on February 27, 2036.
  • Following these transactions, Koka Durga Prasad directly beneficially owns 7,281 shares of common stock and 4,127 employee stock options.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It details routine executive compensation transactions, including performance-based awards and tax-related share dispositions, which are standard disclosures and do not indicate a significant positive or negative shift for the company.

Positives

  • Acquisition of 499 shares of common stock due to the settlement of strategic performance shares, indicating achievement of pre-established company performance goals for the 2023-2025 period.
  • Grant of 2,678 restricted shares and 4,127 employee stock options as part of compensation, aligning executive incentives with long-term company performance.

Negatives

  • Disposition of 122 shares and 98 shares of common stock (total 220 shares) at $287.55 per share to satisfy tax obligations, which reduces direct share ownership.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that routine Form 4 filings, such as this one, are standard disclosures for executive compensation and do not typically reflect broader industry trends or competitive shifts. They primarily provide transparency into insider holdings and compensation structures.

Related Party Transactions

  • The filing details transactions between Cigna Group and its EVP, Global CIO, Durga Prasad Koka, which are inherently related-party transactions as part of executive compensation. These include the settlement of strategic performance shares, grant of restricted shares, and grant of employee stock options.

Stakeholder Impact

  • Shareholders: Provides transparency into executive compensation and share ownership, which can influence investor confidence regarding management alignment. The disposition of shares for tax purposes is a common practice and not indicative of a lack of confidence.
  • Employees: Reflects the company's executive compensation practices, which can indirectly influence broader employee compensation strategies and morale.

Next Steps

  • The 2,678 restricted shares will vest in three equal annual installments beginning March 1, 2027.
  • The 4,127 employee stock options will vest in three equal annual installments beginning March 1, 2027.

Key Dates

DateDescription
02/27/2026Date of earliest transaction for common stock acquisitions, dispositions, and employee stock option grant.
03/01/2027Start date for the vesting of 2,678 restricted shares and 4,127 employee stock options, in three equal annual installments.
02/27/2036Expiration date for the 4,127 employee stock options.
03/02/2026Signature date of the reporting person's attorney-in-fact.

Recommendation

hold

This Form 4 filing details routine executive compensation, including the settlement of performance shares and the grant of new equity awards, along with tax-related share dispositions. Such transactions are standard and do not typically signal a material change in the company's fundamentals or outlook. Therefore, a 'hold' recommendation is appropriate as the filing provides no new information to alter an existing investment thesis.

Keywords

Cigna Group, CI, Form 4, Insider Trading, Stock Options, Restricted Stock, Performance Shares, Executive Compensation, Durga Prasad Koka, EVP Global CIO

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.